Itzel Viridiana Reyes‐Pérez

Cytokines (IL-15, IL-21, and IFN-γ) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity

Itzel Viridiana Reyes‐Pérez, Pedro Ernesto Sánchez‐Hernández, José Francisco Muñóz-Valle et al. · Clinical Rheumatology · 2019 · 32 citations

Inflammation, Rheumatology, Rheumatoid Disorder +15

Impact of Pharmaceutical Education on Medication Adherence and Its Clinical Efficacy in Patients with Type 2 Diabetes and Systemic Arterial Hypertension

Abelardo Contreras-Vergara, Sonia Sifuentes-Franco, Sally Haack et al. · Patient Preference and Adherence · 2022 · 21 citations · Full text

MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients

Sergio Ramírez-Pérez, Rushi Vekariya, Surabhi Gautam et al. · Arthritis Research & Therapy · 2023 · 17 citations · Full text

Myositis-Specific Antibodies and Myositis-Associated Antibodies in Patients With Idiopathic Inflammatory Myopathies From the PANLAR Myositis Study Group

Yelitza González-Bello, Ignacio García-Valladares, Itzel Viridiana Reyes‐Pérez et al. · JCR Journal of Clinical Rheumatology · 2020 · 15 citations

Targeting MyD88 Downregulates Inflammatory Mediators and Pathogenic Processes in PBMC From DMARDs-Naïve Rheumatoid Arthritis Patients

Sergio Ramírez-Pérez, Edith Oregon‐Romero, Itzel Viridiana Reyes‐Pérez et al. · Frontiers in Pharmacology · 2021 · 15 citations · Full text